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Oxidant stress is a ubiquitous stressor with negative impacts on multiple cell types. ASK1 is a central
mediator of oxidant injury, but while mechanisms of its inhibition, such as sequestration by 14-3-3
proteins and thioredoxin, have been identified, mechanisms of activation have remained obscure and the
signaling pathways regulating this are not clear. Here, we report that phosphorylation of 14-3-3 at serine
58 (S58) is dynamically regulated in the cell and that the phosphorylation status of S58 is a critical factor
regulating oxidant stress-induced cell death. Phosphorylation of S58 releases ASK1 from 14-3-3, and
ASK1 then activates stress-activated protein kinases, leading to cell death. While several members of the
mammalian sterile 20 (Mst) family of kinases can phosphorylate S58 when overexpressed, we identify
Ste20/oxidant stress response kinase 1 (SOK-1), an Mst family member known to be activated by oxidant
stress, as a central endogenous regulator of S58 phosphorylation and thereby of ASK1-mediated cell
death. Our findings identify a novel pathway that regulates ASK1 activation and oxidant stress-induced
cell death.
Oxidant stress plays a central role in a wide variety of pa-
thologies, and a critical mediator of oxidant injury is the pro-
tein kinase ASK1 (30). Indeed, ASK1 is required for several
types of oxidant stress-induced cell death (32). Its activity is
restrained by a large number of complementary mechanisms, a
fact that attests to the importance of ASK1 being maintained
in an inactive state in the cell. For example, reduced thiore-
doxin binds to the N-terminal region of ASK1, thereby inhib-
iting its activity (27). Following oxidant stress and oxidation of
thioredoxin, ASK1 is released, allowing its activation. Multiple
phosphorylation events, including phosphorylation of ASK1 at
S83 by Akt and at S1033 by an unknown mechanism, also
negatively regulate ASK1 (6, 41; reviewed in reference 30).
Critical to the negative regulation of ASK1 is phosphorylation
of S966, which drives the association of ASK1 with 14-3-3
proteins, thereby inhibiting ASK1-mediated activation of
downstream signaling and cell death (8, 43). The kinases re-
sponsible for S966 phosphorylation are not known, but the
protein phosphatase calcineurin has been shown to dephos-
phorylate S966, leading to dissociation of ASK1 from 14-3-3
(13). Thus, other than calcineurin-mediated dephosphoryla-
tion of ASK1, signaling mechanisms positively regulating the
release of ASK1 from 14-3-3 proteins are not known, despite
intense interest in this kinase as a potential target in cardio-
vascular and neurologic diseases (30). Therefore, we under-
took studies to attempt to identify such a mechanism.
14-3-3 proteins play protective roles in the cell by seques-
tering proapoptotic factors in a phosphorylation-dependent
manner (1, 15, 23). These proapoptotic proteins that are se-
questered by 14-3-3 proteins are typically phosphorylated on
one or more 14-3-3 binding motifs (18, 39). For example, in
addition to ASK1 phosphorylation at S966, (8, 30), Bad is
phosphorylated by Akt and ribosomal S6 kinases at several
residues, inhibiting its proapoptotic functions (4, 14, 42, 45).
Acting in opposition to this is the well-characterized c-Jun
N-terminal kinase (JNK)-mediated phosphorylation of serine
184 of 14-3-3 proteins, leading to release of the proapoptotic
factors Bax, Bad, FOXO3a, and Abl (29, 33, 40). In addition to
S184, the phosphorylation statuses of other 14-3-3 residues can
regulate 14-3-3/client interactions, such as T233, which is phos-
phorylated by CKI, disrupting the 14-3-3/Raf-1 interaction (5).
Although most of the attention to phosphorylation of 14-3-3
has been focused on S184 and T233 (1), S58 has been known
to be phosphorylated in situ for some time, and several kinases
have been implicated, including protein kinases A and D, Akt,
mitogen-activated protein kinase-activated kinase 2 (MK2),
and sphingosine-dependent protein kinase 1 (later identified as
a cleavage fragment of protein kinase C ) (9, 16, 17, 24, 25,
44). However, it is not clear which specific kinases mediate
phosphorylation under specific circumstances, nor are the bi-
ological consequences clear. This is underscored by the fact
that both pro- and antiapoptotic kinases have been reported to
phosphorylate this residue (23). It does seem clear, however,
that S58 phosphorylation disrupts 14-3-3 dimerization and that
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this reduces the binding of some proteins (e.g., Raf-1) (28, 34),
though probably not all, since Woodcock et al. reported that
14-3-3 monomers phosphorylated at S58 remained competent
to bind phosphopeptides (37).
Thorson et al. and Wang et al. created 14-3-3 mutants that
were deficient in binding phosphopeptides, and Xing et al.
employed one of these, 14-3-3(R56A/R60A), to show that it
led to enhanced activation of the stress-activated protein ki-
nases, JNKs and p38, and enhanced cell death in response to
UVC irradiation, a model of oxidant stress (31, 36, 38). How-
ever, since S58 of 14-3-3 is in the center of the R56-R60
region, we hypothesized that phosphorylation of S58 might
disrupt binding of 14-3-3 to ASK1, which is upstream from the
JNKs and p38 in the response to oxidant stress. In addition,
Preisinger et al. reported that Ste20/oxidant stress response
kinase 1 (SOK-1)/STK25, a mammalian sterile 20 (Mst) family
member also known as yeast sterile 20 kinase 1 (YSK1), phos-
phorylated 14-3-3 on S58, leading to reorganization of the
Golgi structure and cell motility (26). However, we and others
had initially identified SOK-1 as a kinase activated by oxidant
stress (20–22), and we have also shown that SOK-1 exits the
Golgi apparatus following cellular stress (19), potentially giv-
ing SOK-1 greater access to the ASK1/14-3-3 complex (which
is primarily cytosolic). Thus, we hypothesized that oxidant
stress-induced activation of SOK-1 might lead to S58 phosphor-
ylation, release of ASK1 from 14-3-3, activation of JNKs and
p38, and cell death. Here, we confirm these hypotheses and
identify S58 as a molecular switch regulating ASK1-mediated
oxidant stress-induced cell death.
MATERIALS AND METHODS
Antibodies and kinase inhibitors. The antibodies employed included the fol-
lowing: 14-3-3–phospho-Ser 58 (Affinity BioReageagents; PA1-4612); ASK1
(sc7931), SOK-1 (sc-6865), and JNK1 (sc571) (Santa Cruz Biotechnology);
ASK1–phospho-Thr845 (Cell Signaling; no. 3765); and JNK-phospho (Promega;
V7931). The kinase inhibitors used were JNK inhibitor I and the p38 inhibitor
SB239063, both from Calbiochem.
Plasmids. Construction of the 14-3-3 mutants was done as follows. pCINeo,
harboring M2 epitope-tagged wild-type (WT) 14-3-3 cDNA, was constructed as
described by Xing et al. (38). pCINeo-M2-14-3-3–S58A and pCINeo-M2–14-3-
3–S58D were generated with a QuikChange II XL site-directed mutagenesis kit
(Stratagene; no. 200521), following the manufacturer’s instructions. The primers,
purchased from Sigma, were as follows: SA forward primer, 5-GTA GGA GCC
CGT AGG TCA GCT TGG AGG GTC GTC TCA AGT ATT G-3, and SA
reverse primer, 5-CAA TAC TTG AGA CGA CCC TCC AAG CTG ACC TAC
GGG CTC CTA C-3; SD forward primer, 5-GTA GGA GCC CGT AGG TCA
GAT TGG AGG GTC GTC TCA AGT ATT G-3, and SD reverse primer,
5-CAA TAC TTG AGA CGA CCC TCC AAT CTG ACC TAC GGG CTC
CTA C-3. The coding regions of all three plasmids were sequenced. pcDNA3-
HA-ASK1 was constructed as described previously (10). All restriction enzymes
were purchased from New England Biolabs.
Cells and cell culture. ASK1/ and ASK1/ mouse embryo fibroblasts
(MEFs) were generated as described previously (32). The cells were maintained
in MEF growth medium (Dulbecco’s modified Eagle’s medium [DMEM] with
10% fetal calf serum, supplemented with L-glutamine, nonessential amino acids
[Gibco; no. 25030-050], and 1% penicillin-streptomycin) in 5% CO2 at 37°C.
NIH 3T3 fibroblasts were from ATCC (CRL-1658) and were maintained in
DMEM with 10% bovine calf serum, 1% penicillin-streptomycin in 5% CO2
at 37°C.
Transfection. Cells were transfected using the FuGENE 6 reagent (Roche; 11
814 443 001) following the manufacturer’s instructions. Transfection efficiency
with this protocol is 60 to 70%.
Coimmunoprecipitation. Cells were lysed in lysis buffer (50 mM Tris-HCl, pH
7.4, 1 mM EDTA, 150 mM NaCl, 1% NP-40, and protease inhibitor cocktail and
phosphatase inhibitor cocktail [P8430 and P2850, respectively; both from
Sigma]). EZview Red Anti-FLAG M2 affinity gel beads conjugated with anti-
FLAG M2 monoclonal antibody (Sigma; F2426) were used for coimmunopre-
cipitation, following the manufacturer’s instructions. The beads were washed five
times in lysis buffer, followed by the addition of sodium dodecyl sulfate-poly-
acrylamide gel electrophoresis (SDS-PAGE) sample buffer.
Immunoblotting and densitometry. Following SDS-PAGE and transfer to a
nitrocellulose membrane, primary antibody incubations were performed at the
following dilutions: 14-3-3–pSer58, 1:1,000; 14-3-3, 1:1,000; ASK1, 1:500;
ASK1-pThr845, 1:500; SOK-1, 1:1,000; JNK1, 1:1,000; and JNK-p, 1:4,000. All
incubations were done at 4°C overnight. The secondary antibody used was Alexa
Fluor 680 (Molecular Probes) at 1:3,000 dilution for 1 h at room temperature.
The membranes were scanned with the Odyssey infrared imaging system (Li-
Cor). The densities of target bands were quantified using the application soft-
ware of the Odyssey infrared imaging system. Band density was normalized to
that of the GAPDH (glyceraldehyde-3-phosphate dehydrogenase) loading con-
trol.
Determination of apoptosis employed terminal deoxynucleotidyl transferase
dUTP nick end labeling (TUNEL). Cells were plated on chamber slides for 24 h,
serum starved for 2 h, and then treated with 125 M H2O2 for 2 h, followed by
an additional incubation for 1 h in culture medium (DMEM) prior to fixation.
Identification of apoptotic cells was done with the apoptosis detection kit from
Chemicon (S7111), by following the manufacturer’s instructions. For experi-
ments in which transfection was required, cells were transfected 24 h after being
plated. After an additional 24 h, the cells were exposed to 125 M H2O2 for 3 h
and processed as described above.
The percentage of apoptotic cells (i.e., the apoptotic index, or the number of
TUNEL-positive cells per 100 cells) was determined by counting the cells in five
predefined regions of the slides (the four corners and the middle of each well).
The total number of cells counted was 1,000 to 1,200 per well. In some
instances, it was necessary to count up to nine areas of a slide.
siRNA-mediated RNA interference. Small interfering RNAs (siRNAs) for
SOK-1 (D-065319-04-0010 and On-Targetplus Smartpool, a pool of four
siRNAs—J065319-05, J-065319-06, J065319-07, and J-065319-08) and for Mst2
(D-040440-04-005) were from Dharmacon. Control siRNA was from Ambion
(Silencer Negative Control no. 2; AM4613). On the day before transfection, cells
were plated in antibiotic-free medium and were incubated overnight. The cells
were then transfected using DharmaFect1, T-2001, with a final siRNA concen-
tration of 100 nM of the siRNA of interest or control siRNA, following the
manufacturer’s instructions. The cells were incubated for an additional 72 hours
prior to performing experiments.
Statistical analyses. We employed Student’s t test to analyze densitometry
data. The chi square test was used to determine the significance of the TUNEL
studies. A P value of  0.05 was considered statistically significant. The data are
presented as means 	 standard errors of the means (SEM).
RESULTS
To explore the potential role of S58 phosphorylation in
regulating cell death, we examined cell death induced by the
universal stressor oxidant stress in NIH 3T3 fibroblasts. First,
we employed a phosphospecific antibody for S58 to examine
the mechanisms and consequences of S58 phosphorylation.
This antibody indeed appeared to be highly selective for S58-
phosphorylated 14-3-3 based on the results of competition
studies performed by the manufacturer. In these studies, the
phosphopeptide used to generate the antibody completely
competed out phospho-S58 antibody binding to 14-3-3,
whereas the nonphosphopeptide had no effect on binding of
the antibody. Furthermore, phospho-S58 antibody binding
was eliminated by prior treatment of 14-3-3 with 
 phos-
phatase (data available from and provided to us by the
manufacturer). We repeated the peptide competition stud-
ies and confirmed the selectivity of the antibody for S58-
phosphorylated 14-3-3 (Fig. 1A).
We then examined the phosphorylation status of S58 and
found that it was dynamically regulated in response to oxi-
dant stress induced by H2O2 (Fig. 1B and C). To further test
the specificity of the phosphoantibody, we expressed WT
14-3-3 or 14-3-3 with an S58-to-A mutation (SA) prevent-
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ing phosphorylation, and then exposed the cells to H2O2.
This induced a marked increase in phosphoantibody binding
to WT 14-3-3 but virtually no binding to SA 14-3-3 (Fig.
1D). Thus, oxidant stress triggers S58 phosphorylation, and
this phosphorylation can be monitored by the phosphospe-
cific antibody.
We next explored the biological consequences of Ser 58
phosphorylation by inducing oxidant stress in cells expressing
FIG. 1. Phosphorylation of Ser 58 in response to oxidant stress. (A) Peptide competition studies to validate the selectivity of anti-phospho-Ser 58
antibody (Ab). Cells were transfected with vectors harboring WT 14-3-3 tagged with HA and M2 epitopes. Twenty-four hours later, the cells were treated
with H2O2 (125 M) for 3 h. The lysates were run on SDS-PAGE and then transferred to nitrocellulose. The membranes were then probed overnight
with the anti-phospho-Ser 58 Ab in the presence of either no competing peptide (lane 1), unphosphorylated peptide (100 ng/ml) (lane 2), or
phosphorylated peptide (100 ng/ml) (lane 3) (phosphopeptide sequence, CGARRSpSerWRVVS). The lysate was also probed with anti-M2 (lane 4) to
confirm the location of M2–14-3-3. The location of endogenous 14-3-3 is also shown. Incubation with phosphopeptide, but not unphosphorylated
peptide, eliminated binding of anti-phospho-Ser 58 Ab. (B) Time course of oxidant stress-induced phosphorylation of Ser 58 of 14-3-3. NIH 3T3 cells
were treated with H2O2 (125 M) for the times shown, and then the lysates were blotted with the anti-phospho-Ser 58 Ab, anti-14-3-3, or GAPDH (used
throughout as a loading control). Quantitation of three independent experiments is shown below. *, P  0.05 versus time zero; #, P  0.01 versus time
zero. The error bars indicate SEM. (C) Dose response of oxidant stress-induced phosphorylation of Ser 58 of 14-3-3. NIH 3T3 cells were treated with
H2O2 at the concentrations shown for 60 min, and then the lysates were blotted with the anti-phospho-Ser 58 Ab, anti-14-3-3, or GAPDH. Quantitation
of three independent experiments is shown below. *, P 0.05 versus 0M; #, P 0.01 versus 0M. (D) S58 phospho-specific Ab recognizes WT 14-3-3
after H2O2, but not SA 14-3-3. Cells were transfected with vector control (VC), WT M2–14-3-3, or SA M2–14-3-3 and then were exposed to vehicle
(CTL) versus H2O2. The lysates were immunoblotted with anti-phospho-S58 Ab (top), M2 Ab (middle), or GAPDH Ab (bottom).
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SA versus WT 14-3-3. Expression of either WT or SA 14-3-3
partially protected cells from oxidant stress-induced cell death,
with expression of SA 14-3-3 being more protective (Fig. 2A).
Thus, the inability to phosphorylate Ser 58 of 14-3-3 reduces
oxidant stress-induced cell death.
These findings suggested the possibility that oxidant stress-
induced release of a proapoptotic factor from 14-3-3 was
prevented by the nonphosphorylatable SA mutation. Serine 58
is within a region known to be required for binding to ASK1.
Therefore, we coexpressed ASK1 and the various 14-3-3 mu-
tants to examine the effects of the phosphorylation status of
S58 on the ASK1/14-3-3 interaction. ASK1 readily bound to
WT and SA 14-3-3, but minimal if any binding to 14-3-3 with
an S58-to-D (SD) mutation could be detected (Fig. 2B). These
data suggest that the phosphorylation status of S58 determines
whether ASK1 is sequestered by 14-3-3.
To explore this further, we asked whether the interaction of
ASK1 with 14-3-3 was dynamically modulated in response to
oxidant stress. We found that oxidant stress induced dissocia-
tion of ASK1 from WT 14-3-3, but not from SA 14-3-3 (Fig.
FIG. 2. The Ser 58 phosphorylation status regulates the ASK1/14-3-3 interaction, ASK1 activation, and cell survival. (A) Expression of SA
14-3-3 protects against oxidant stress-induced cell death. NIH 3T3 cells were transfected with vector (VC), M2-tagged WT 14-3-3, or M2-tagged
SA 14-3-3 for 24 h. The cells were then exposed to vehicle (H2O) or H2O2 (125 M) as described in Materials and Methods, followed by staining
for TUNEL (top). Quantification of the percent TUNEL-positive cells (middle) demonstrated a reduction in cell death with the WT compared
to VC and a more marked reduction with SA 14-3-3. Immunoblotting with anti-M2 antibody confirmed equivalent expression of WT and SA
14-3-3 in the experiments (bottom). *, P  0.01 versus VC; #, P  0.01 versus WT. The error bars indicate SEM. (B) The phosphorylation status
of 14-3-3 regulates the 14-3-3/ASK1 interaction. NIH 3T3 cells were transfected with hemagglutinin (HA)-tagged ASK1 (HA-ASK1 ) or vector
(HA-ASK1 ) and with the various M2-tagged 14-3-3 constructs () or vector () as shown. Twenty-four hours later, the lysates were prepared
and then were immunoprecipitated (IP) with M2 antibody (Ab) (pulling down 14-3-3), followed by immunoblotting (IB) with anti-HA Ab (for
ASK1). Immunoblots of lysates are shown in below. Note the coimmunoprecipitation of WT and SA 14-3-3 with ASK1 (top, lanes 4 and 6 from
left) but no coimmunoprecipitation of SD 14-3-3 with ASK1 (lane 8 from left), despite comparable levels of expression of SD and WT 14-3-3
(bottom, 14-3-3, compare lane 8 to lane 4) and greater expression of SD than SA 14-3-3 (bottom, compare lane 8 with lane 6). Thus, mutation
of S58 to the phosphomimetic D58 disrupts 14-3-3 and ASK1 binding. Molecular mass (M) markers are shown on the right. (C) Oxidant stress
induces dissociation of ASK-1 from WT 14-3-3 but not from SA 14-3-3. 3T3 cells were transfected with ASK1 and either M2-tagged WT 14-3-3,
M2-tagged SA 14-3-3, or vector control (VC). The cells were then treated with H2O2 or vehicle () for 60 min. The lysates were immunopre-
cipitated with anti-M2 Ab, and the blots were probed with anti-ASK1. Oxidant stress induced significantly greater dissociation of ASK1 from WT
than from SA 14-3-3 (compare lanes 4 and 6 from left). Quantification is shown below. **, P  0.01. (D) The phosphorylation status of S58 of
14-3-3 regulates the ASK1 activation state. 3T3 cells were transfected with VC versus WT, SA, or SD 14-3-3 for 24 h and then were subjected
to H2O2 (125 M) for 1 h. The lysates were immunoblotted with an anti-phospho-ASK1 Ab that recognizes phosphorylation of the activation loop
Thr residue (T838 in human ASK1 and T845 in mouse ASK1). Expression of SA 14-3-3 reduced, and SD 14-3-3 enhanced, oxidant stress-induced
phosphorylation of T845 (compare lane 6 from left [WT] with lanes 7 and 8). Also note that phosphorylation of ASK1 in SA 14-3-3-transfected
cells was less than in VC-transfected cells despite higher levels of expression of ASK1 in SA 14-3-3-transfected cells (compare ASK1 blot lane
5 to lane 7). (E) The serine 58 phosphorylation status regulates oxidant stress-induced cell death. 3T3 cells were transfected with ASK1 and either
VC or one of the 14-3-3 constructs and then were treated with vehicle or H2O2 (125 M) for an additional 24 h. The percentages of
TUNEL-positive cells were then determined. Expression of WT or SA 14-3-3 reduced, whereas expression of SD 14-3-3 increased, oxidant
stress-induced cell death. *, P  0.01 versus VC; #, P  0.01 versus WT and SA 14-3-3. (F) ASK1 is the 14-3-3 interactor that is regulated by
the S58 14-3-3 phosphorylation status and mediates oxidant-induced cell death. (Top) ASK1/ MEFs were transfected with VC or SA or SD
14-3-3 as described above. The cells were then exposed to vehicle (VC) versus H2O2 (125 M), and the percentages of TUNEL-positive cells were
determined. In WT MEFs, as in 3T3 cells, SA 14-3-3 decreased oxidant stress-induced cell death. (Middle) ASK1/ MEFs were transfected with
VC or SA or SD 14-3-3 and then were exposed to vehicle versus H2O2 (125 M). The percentages of TUNEL-positive cells were determined.
Deletion of ASK1 nearly abolished oxidant stress-induced cell death, and detrimental effects of SD 14-3-3 were not seen in the absence of ASK1.
(Bottom) ASK1/ MEFs were transfected with ASK1 and either VC or SA or SD 14-3-3 prior to treatment with H2O2 as described above.
Reintroduction of ASK1 into the ASK1/ MEFs restored oxidant stress-induced death, and as in ASK1/ MEFs, this was significantly reduced
by expression of SA but not by expression of SD 14-3-3. (G) Activation of the ASK1 targets, the JNK family of stress-activated kinases, is also
regulated by the 14-3-3 phosphorylation status. 3T3 cells were transfected with ASK1 and either VC or WT, SA, or SD 14-3-3. The cells were
then treated with vehicle versus H2O2 for 1 h. The lysates were immunoblotted with anti-T183/Y185 JNK phosphospecific antibody and with
antibodies to total JNK1 and JNK2. Note the lower level of phospho-JNK1 and -JNK2 in WT and SA 14-3-3-transfected cells (top, lanes 6 and
7 from left) compared to VC- or SD 14-3-3-transfected cells (lanes 5 and 8). Thus, as with ASK1, JNK activation is regulated by the S58
phosphorylation status. (H) JNKs and p38-MAPK mediate the increased oxidant stress-induced cell death seen with SD 14-3-3. 3T3 cells were
transfected with ASK1 and SD 14-3-3 and then were exposed to vehicle versus H2O2 (125 M), either in the presence of the JNK inhibitor peptide
(Inhibitor 1; 1 M), the p38 inhibitor SB239063 (10 M), or no inhibitor. *, P  0.05 versus no inhibitor; #, P  0.01 versus no inhibitor.
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FIG. 3. SOK-1 is a Ser 58 kinase that regulates oxidant stress-induced cell death. (A) Expression of SOK-1 increases phosphorylation of Ser
58 of 14-3-3. (Top) Cells were transfected with SOK-1 () or vehicle control (VC) () and either WT 14-3-3 () or VC (). Twenty-four hours
later, cell lysates were prepared and blotted with the anti-phospho-Ser 58 antibody. (Bottom) Cells were transfected as described above.
Twenty-four hours later, the cells were exposed to H2O2 for 40 min. The lysates were immunoblotted for 14-3-3 S58 phosphorylation or GAPDH.
(B) SOK-1 is necessary for Ser 58 phosphorylation. (Top) Cells were transfected with an siRNA to SOK-1 or a control siRNA for 48 h and then
were treated with H2O2 or vehicle. At the times shown, lysates were prepared and immunoblotted for SOK-1, phospho-Ser 58 14-3-3, total 14-3-3,
or GAPDH. (Bottom) Cells were transfected with the second SOK-1 siRNA versus control siRNA as described above and then stimulated with
H2O or H2O2 for 40 min. The lysates were immunoblotted for SOK-1, phospho-JNK, or total JNK. (C) Mst2 is not necessary for Ser 58
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2C). Functionally, the S58 phosphorylation status not only
regulates 14-3-3/ASK1 binding, but also regulates ASK1 ac-
tivity, since expression of SA 14-3-3 decreased oxidant stress-
mediated phosphorylation of T845 within the activation loop
of ASK1, whereas expression of SD 14-3-3 increased phos-
phorylation of T845 (Fig. 2D).
To further examine the biological consequences of S58 phos-
phorylation, we coexpressed ASK1 with WT, SA, or SD 14-
3-3 and found that H2O2-induced cell death was significantly
reduced by expression of SA 14-3-3 and was increased by
expression of SD 14-3-3 (Fig. 2E). The increase in cell death
with expression of SD 14-3-3, which was a consistent trend
throughout these studies, is consistent with SD acting as not
only a loss of function mutation but as a dominant negative,
similar to findings by Xing et al. with the R56A/R60A mutant
(38).
Many factors bind to 14-3-3, and any of them could be
regulated by the S58 phosphorylation status and could account
for the regulation of oxidant stress-induced cell death. We
therefore examined whether ASK1 was the specific mediator
of cell death that was regulated by the S58 phosphorylation
status. Consistent with our findings in NIH 3T3 fibroblasts,
expression of SA 14-3-3 in WT MEFs protected the cells from
oxidant stress-induced cell death, whereas expression of SD
14-3-3 tended to enhance injury (Fig. 2F, top). In contrast,
ASK1/ MEFs were largely protected against oxidant injury,
and expression of SA or SD 14-3-3 had little effect on cell
death in these cells (Fig. 2F, middle). When ASK1 was trans-
fected into ASK1/ MEFs, SA 14-3-3 was again protective,
whereas SD 14-3-3 enhanced injury (Fig. 2F, bottom). Thus,
regulation of cell death by the phosphorylation status of S58 of
14-3-3 appears to be mediated in large part via effects
on ASK1.
We next reasoned that if the effect of the Ser 58 phosphor-
ylation status on oxidant stress-induced cell death was medi-
ated by ASK1, then the downstream pathways regulating death
might be the JNK family of stress-activated protein kinases,
since they play key roles in mediating the proapoptotic effects
of ASK1. We found that oxidant stress-induced activation of
JNKs was significantly reduced in cells expressing WT 14-3-3
and was even more reduced by expression of SA 14-3-3 (Fig.
2G). In contrast, JNK activation was not reduced in cells ex-
pressing SD 14-3-3 (Fig. 2G). Furthermore, a peptide antag-
onist of JNKs, based on the JNK binding domain of JIP1,
significantly decreased death in cells expressing SD 14-3-3
(Fig. 2H). Similar results were seen for p38-MAPK, since the
small molecule inhibitor SB239063 also significantly protected
cells expressing SD 14-3-3 (Fig. 2H). These data are consis-
tent with a central role for stress-activated protein kinase sig-
naling downstream of the ASK1/14-3-3 module in oxidant
stress-induced cell death.
We then explored kinases that might mediate phosphoryla-
tion of S58 in the setting of oxidant stress. As noted, the p38
target, MK2, and protein kinase C  had been reported to be
S58 kinases. However, neither SB239063 nor either of two
protein kinase C  inhibitors, bisindolylmaleimide (Go¨6850)
and Go¨6983, altered oxidant stress-induced phosphorylation of
S58 (data not shown).
We then turned to the Mst family of protein kinases, since as
noted, one member, SOK-1, was initially identified as a kinase
that was activated by oxidant stress and was later reported to
phosphorylate S58 of 14-3-3. Consistent with the prior report
(26), expression of SOK-1 induced phosphorylation of S58
(Fig. 3A, top). Thus, SOK-1 is sufficient to induce S58 phos-
phorylation. Furthermore, expression of SOK-1 increased ox-
idant stress-induced S58 phosphorylation (Fig. 3A, bottom). In
addition, siRNA-mediated knockdown of SOK-1 reduced
basal phosphorylation of Ser 58 and largely prevented any
increase in phosphorylation following H2O2 treatment (Fig.
3B, top). SOK-1 knockdown also significantly reduced oxidant
stress-induced phosphorylation of JNK, the downstream target
of the pathway (Fig. 3B, bottom). In contrast, although Mst2,
another Mst family member that is activated by oxidant stress,
phosphorylated S58 when overexpressed (data not shown),
siRNA-mediated knockdown of Mst2 had no effect on S58
phosphorylation (Fig. 3C). Furthermore, the closely related
Mst4 does not phosphorylate S58 of 14-3-3 (26), and MstI is
expressed at extremely low to undetectable levels in NIH 3T3
cells (2, 3). Thus, of the Mst family members, SOK-1 appeared
to be an important S58 kinase in these cells.
Consistent with the SOK-1/14-3-3/ASK1 module being a
central mechanism mediating oxidant stress-induced cell
death, expression of SOK-1 amplified oxidant stress-induced
cell death (Fig. 3D, top) and knockdown of SOK-1 via siRNA
significantly reduced H2O2-induced cell death (Fig. 3D, bot-
tom). The latter finding was confirmed with a second siRNA to
SOK-1 (see Fig. S1 in the supplemental material). That SOK-1
indeed acts via S58 phosphorylation to induce cell death is
suggested by the finding that cell death induced by expression
of SOK-1 was significantly reduced by coexpression of SA
14-3-3 and was partially inhibited by expression of WT 14-3-3
(Fig. 3E).
phosphorylation in 3T3 cells. Cells were transfected with Mst2 siRNA or control siRNA and then treated with H2O2 or vehicle. The lysates were
immunoblotted for Mst2 or phospho-Ser 58 14-3-3. Despite successful knockdown of Mst2, phosphorylation of 14-3-3 at S58 was not affected.
(D) SOK-1 regulates oxidant stress-induced cell death. (Top) Cells were transfected with SOK-1 or VC and then were exposed to H2O2 versus
vehicle prior to determination of the percentage of TUNEL-positive cells. Expression of SOK-1 induced cell death and enhanced oxidant
stress-induced death. *, P  0.01 versus VC. (Bottom) Cells were transfected with siRNA to SOK-1 versus control siRNA for 48 h, and then were
exposed to H2O2 versus vehicle. The TUNEL-positive cells were then quantified. Knockdown of SOK-1 reduced oxidant stress-induced cell death.
*, P 0.01 versus VC; #, P 0.01 versus control siRNA treated with H2O2; N.S., not significant. The error bars indicate SEM. (E) SOK-1-induced
cell death is inhibited by 14-3-3. Cells were transfected with SOK-1 versus VC and either WT or SA 14-3-3 or VC for 24 h prior to determining
the percentage of TUNEL-positive cells. *, P  0.01 versus VC; # P  0.05 versus WT. (F) SOK-1 enhances activation of ASK1. Cells were
transfected with SOK-1 () versus vector () and either ASK1 () or vector (). The cells were then exposed to vehicle versus H2O2 for 1 h.
The lysates were immunoblotted with anti-phospho-ASK1 (Thr 845). SOK-1 enhanced the oxidant stress-induced phosphorylation of Thr 845
(compare lanes 6 and 8 from left).
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To further confirm SOK-1 as a regulator of the 14-3-3/ASK1
module, we cotransfected ASK1 and SOK-1 and then exam-
ined the effects of this on ASK1 and JNK activation. We found
that SOK-1 expression modestly increased phosphorylation of
T845 of ASK1 but more markedly enhanced oxidant stress-
induced phosphorylation of T845 (Fig. 3F).
DISCUSSION
ASK1 is a central regulator of oxidant stress-induced cell
death. Critical to this is the release of ASK1 from 14-3-3
proteins (38, 43). Although the mechanism driving ASK1 bind-
ing to 14-3-3 proteins via S966 phosphorylation was known,
signaling mechanisms regulating the release of ASK1 from
14-3-3 proteins were not, despite intense interest in this kinase
(8). In this paper, we identify a novel mechanism that regulates
oxidant stress-induced cell death. We show that following
oxidant stress, the Mst family member SOK-1/YSK1 phosphor-
ylates 14-3-3 at S58, thereby disrupting ASK1 binding to 14-
3-3, allowing ASK1 activation and inducing cell death.
As noted above, S58 had been known to be phosphorylated
in situ for some time, but the mechanisms regulating this and
the biological consequences of that phosphorylation were not
known until the effects on Golgi apparatus reorganization and
cell motility were reported (26). Our studies indicate that a
major biological role of S58 phosphorylation is triggering oxi-
dant stress-induced cell death. This is the first direct demon-
stration of a proapoptotic role and regulation of a proapoptotic
factor (ASK1) by S58 phosphorylation.
A large number of proteins bind to 14-3-3 proteins. In fact
14-3-3 alone has been demonstrated to interact with at least
20 partners (25, 35). Thus, S58 phosphorylation could disrupt
the binding of a number of factors, any of which might be
responsible for the cell death seen in the cells expressing SD
14-3-3. Thus, the studies of ASK1/ MEFs that specifically
implicate ASK1 as a key mediator are critical. However, the
enhancement of cell death by expression of SD 14-3-3 cer-
tainly raises the possibility that binding of proapoptotic factors
in addition to ASK1 may be regulated by S58 phosphorylation
and/or that S58-phosphorylated 14-3-3 is not only incompe-
tent to bind ASK1, but cannot effectively dimerize with other
14-3-3 molecules, leading to release of ASK1 and other fac-
tors, thereby enhancing injury.
Ser 58 of 14-3-3 and the sequence surrounding it is
broadly conserved across species from Drosophila to hu-
mans. Furthermore, five of seven 14-3-3 isoforms in mouse,
rat, dog, and human have S58 conserved, suggesting that S58
phosphorylation likely plays a role in regulating the inter-
actions of all of these isoforms with client proteins (7). This
makes it difficult, if not impossible, to examine the role of
S58 phosphorylation of specific 14-3-3 isoforms by employ-
ing knockdown strategies, since compensation by other iso-
forms would be expected unless one isoform is dominant in
a particular cell type. Intriguingly, S58 is not conserved in
sigma and tau/theta. Rather, these isoforms have an alanine
residue in this position. Our findings would predict that
these isoforms might constitutively sequester ASK1 and
might be particularly protective against oxidant stress. Con-
sistent with this hypothesis, mice with heterozygous deletion
of 14-3-3, which is normally highly expressed in the heart,
were much more susceptible to oxidant stress-induced or
ischemia-induced injury, the latter being a setting in which
oxidant stress plays a major role in injury (11). In the hearts
of 14-3-3(/) mice, ASK1, JNK, and p38-MAPK activities
were increased. We believe our studies now provide a mech-
anism for these findings.
The mechanism of oxidant stress-induced cell death that we
have identified may be complementary to the MstI/FOXO
pathway that has recently been shown to regulate oxidant in-
jury in rat cerebellar neurons (12). In that case, MstI phosphor-
ylated FOXO3a, resulting in the release of FOXO3a from
14-3-3 proteins and induction of the expression of cell death
genes. It is very unlikely that the MstI/FOXO mechanism
could have played a significant role in our experiments since, as
noted, MstI is expressed at very low or undetectable levels in
NIH 3T3 fibroblasts (2, 3). That said, the expression patterns
of Mst proteins differ, with Mst2, for example, being expressed
at very low levels in the heart, lung, liver, and brain, whereas
SOK-1 is highly expressed in lung and brain, tissues of the
gastrointestinal tract, and, to a somewhat lesser extent, the
heart and liver. Thus, since MstI and Mst2 are capable of
phosphorylating Ser 58 when overexpressed (data not shown),
it is possible that MstI and/or Mst2 could also function as an
S58 kinase in cell types in which they are more highly ex-
pressed.
How do such different biological responses as Golgi appa-
ratus reorganization and cell death result from activation of
the same kinase, phosphorylating the same substrate at the
same residue? In nonstressed cells, SOK-1 appears to exist in
two pools—an inactive cytosolic pool and an active Golgi pool
FIG. 4. Schematic of the SOK-1/14-3-3/ASK1 pathway. Following
oxidant stress, SOK-1 exits the Golgi apparatus and interacts with the
14-3-3/ASK1 complex, phosphorylating Ser 58 of 14-3-3. This leads
to dissolution of the 14-3-3/ASK1 complex, allowing the ASK1 signa-
losome to form (30), which includes TRAF2 and TRAF6. ASK1 then
activates JNKs and p38-MAPKs, culminating in cell death. Also shown
is SOK-1 translocation to the nucleus, which has been shown to play a
role in chemical-anoxia-induced cell death (19).
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(Fig. 4). As noted above, we have reported that exposure of
cells to chemical anoxia, a cell culture model of ischemia, leads
to exit of SOK-1 from the Golgi apparatus, and this plays an
important role in chemical-anoxia-induced cell death (19). We
also found that SOK-1 exits the Golgi apparatus in cells ex-
posed to oxidant stress (data not shown). We suggest that the
very different biological responses resulting from SOK-1 acti-
vation and S58 phosphorylation are critically dependent on the
subcellular localization of activated SOK-1 and its target, 14-
3-3. Since ASK1 (and the ASK1/14-3-3 complex) is predom-
inantly cytosolic, it appears that SOK-1 may need to exit the
Golgi apparatus in order to induce maximal release of ASK1
and cell death. Indeed, regulation of subcellular localization in
stressed versus nonstressed cells may be a central mechanism
regulating SOK-1 biological functions.
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